Nutrimed Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.10 Cr
- Paid Up Capital ₹ 3.51 Cr
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -99.94%
- Profit Growth 82.33%
- Ebitda -106.10%
- Net Worth -0.24%
- Total Assets 35.00%
About Nutrimed Life Sciences
Nutrimed Life Sciences Private Limited (NLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 March 2017 (Seven years and 11 months 9 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Corporate was formerly known as Delvin Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.10 Cr and a paid-up capital of Rs 3.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jegadheesan Kumar and Jaiganesh serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24297TN2017PTC115216
-
Company No.
115216
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Mar 2017
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Nutrimed Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jegadheesan Kumar
|
Director | 21-Mar-2018 | Current |
|
Jaiganesh
|
Additional Director | 10-Oct-2022 | Current |
Financial Performance of Nutrimed Life Sciences.
Nutrimed Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.94% decrease. The company also saw a substantial improvement in profitability, with a 82.33% increase in profit. The company's net worth dipped by a decrease of 0.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutrimed Life Sciences?
In 2022, Nutrimed Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lifespan Diagnostic LlpJegadheesan Kumar is a mutual person
-
Thousand Pillars Technologies Private Limited
Jegadheesan Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutrimed Life Sciences?
Unlock and access historical data on people associated with Nutrimed Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutrimed Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutrimed Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
